AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Capital expenditures

LTT Bio-Pharma Co., Ltd.【JP:E00982】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-22+1297.07%
Mar 31, 2024-2+23.56%
Mar 31, 2023-1-28.67%
Mar 31, 2022-2+14.77%
Mar 31, 2021-2+617.59%
Mar 31, 2020-0-90.24%
Mar 31, 2019-2+93.03%
Mar 31, 2018-1-25.18%
Mar 31, 2017-2+16.67%
Mar 31, 2016-1+75.20%
Mar 31, 2015-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)